Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: A retrospective data analysis
References (42)
- et al.
Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities
J Clin Epidemiol.
(1994) - et al.
The effects of initial drug choice and comorbidity on antihyperten sive therapy compliance: Results from a population-based study in the elderly
Am J Hypertens
(1997) - et al.
Appropriate reductions in compliance among well-controlled hyper tensive patients
J Clin Epidemiol.
(1991) - et al.
Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a Medicaid population of asthmatic patients
Clin Ther.
(1998) Diabetes statistics
(2005)National Diabetes fact sheet: National estimates and general information on diabetes in the United States
(2004)- et al.
The rising global burden of diabetes and its complications: Estimates and projections to the year 2010
Diabet Med.
(1997) - et al.
Economic costs of diabetes in the US in 2002
Diabetes Care
(2003) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
N Engl J Med.
(1993)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
(1998)
Effect of improved glycemic control on health care costs and utilization
JAMA
Care of adults with type 2 diabetes mellitus. A review of the evidence
J Farn Pract.
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
BMJ
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49)
JAMA
Interventions to improve the management of diabetes in primary care, outpatient, and community settings: A systematic review
Diabetes Care
Unequal treatment confronting racial and ethnic disparities in healthcare
A diabetes report card for the United States: Quality of care in the 1990s
Ann Intern Med.
Racial and ethnic differences in glycemic control of adults with type 2 diabetes
Diabetes Care
Medication adherence and diabetes control in urban African Americans with type 2 diabetes
Health Psychol.
The association between diabetes metabolic control and drug adherence in an indigent population
Diabetes Care
Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: A retrospective data analysis
Curr Med Res Opin.
Cited by (37)
Pharmacological treatment of type 2 diabetes in Saudi Arabia: A consensus statement from the Saudi Society of Endocrinology and Metabolism (SSEM)
2021, Diabetes and Metabolic Syndrome: Clinical Research and ReviewsCitation Excerpt :Adherence to religion and culture is widely cherished and respected in Saudi Arabia. Adherence to medications is generally poor among people with T2D and this has been linked to lower attainment of treatment targets for hemoglobin A1C (HbA1C), blood pressure, and low-density lipoprotein (LDL) cholesterol, and consequently higher healthcare costs and poorer clinical outcome [5–12]. Although, the importance of patient’s adherence to medications is recognized in the general guidelines documents, it is however, not prioritized or listed as a deciding factor in the choice of glucose-lowering agents recommended in any of the current treatment algorithms of T2D.
Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure
2017, Health PolicyCitation Excerpt :The impact of a $5 increase in copayment on the percentage of patients being adherent was examined in three studies (p < 0.05) (two in DM [46,51] and one in HF [49]) and all studies concluded in a statistically significant (p < 0.05) decrease of adherent patients. Among the 29 studies examined the relationship between medication adherence and resource utilization, health and/or economic outcomes, 22 [44,50,59–78] had been conducted in DM populations, six [53–58] in patients with HF, while both patients with DM or HF were included in one study [79]. Ten [44,59,60,63,64,70,71,73,75,76] out of twelve studies evaluating the impact of medication adherence change on health outcomes among patients with DM demonstrated a statistically significant (p < 0.05) association.
Impact of nonadherence on complication risks and healthcare costs in patients newly-diagnosed with diabetes
2017, Diabetes Research and Clinical PracticeFactors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population
2014, Research in Social and Administrative PharmacyCitation Excerpt :Previous research reports mixed findings regarding the effects that age, gender, and race have in compliance with drug therapy across varying chronic conditions. Age, gender, and race have been significant predictors in logistic regression models,18,21 with males having better adherence levels than females,18 White patients having better adherence levels than Black patients,18,22,43–46 and older patients having better adherence levels than younger patients.11 In the current study, no significant effects were seen on either persistence or adherence due to age, but the effects due to gender and race were the same as other studies.
The effect of prescribed fluid consumption on physiology and work behavior of wildfire fighters
2013, Applied ErgonomicsThe association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder
2012, Research in Social and Administrative Pharmacy